Jefferies Group’s Usana Health Sciences USNA Stock Holding History

Jefferies Group’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-6,700	Closed	-$654K	–	2012
2021 Q1	$654K	Buy	+6,700	New	+$610K	0.01%	1042
2018 Q4	–	Sell	-2,773	Closed	-$334K	–	2595
2018 Q3	$334K	Buy	+2,773	New	+$344K	﹤0.01%	1822
2018 Q2	–	Sell	-7,271	Closed	-$625K	–	2699
2018 Q1	$625K	Buy	7,271 +4,085	+128%	+$316K	﹤0.01%	1395
2017 Q4	$236K	Sell	3,186 -5,289	-62%	-$354K	﹤0.01%	2131
2017 Q3	$489K	Buy	+8,475	New	+$501K	﹤0.01%	1644
2017 Q2	–	Sell	-6,803	Closed	-$392K	–	2587
2017 Q1	$392K	Sell	6,803 -435	-6%	-$26K	﹤0.01%	1716
2016 Q4	$443K	Buy	+7,238	New	+$472K	﹤0.01%	1638
2015 Q3	–	Sell	-1,492	Closed	-$102K	–	3052
2015 Q2	$102K	Buy	+1,492	New	+$94.7K	﹤0.01%	2212

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Jefferies Group's USNA Position: Q2 2021 in Review

Jefferies Group sold out of Usana Health Sciences (USNA) in Q2 2021, closing a stake of 6,700 shares — an estimated $654K sold.

Jefferies Group first reported a position in USNA in Q2 2015 and held it in 8 quarters. The position peaked at $654K in Q1 2021. 188 funds tracked by Wall St. Rank hold USNA as of Q2 2021.

Jefferies Group reported no remaining Usana Health Sciences position as of Q2 2021 after selling out during the quarter.
Jefferies Group sold 6,700 Usana Health Sciences shares in Q2 2021, an estimated $654K.
Jefferies Group first reported a position in Usana Health Sciences in Q2 2015 and held it in 8 quarters.
Jefferies Group's Usana Health Sciences position peaked at $654K in Q1 2021.
188 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2021.

Based on Jefferies Group's 13F filing for Q2 2021, filed 16 Aug 2021.